Literature DB >> 20568066

[Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation].

María D Cuenca-López1, David Brea, María F Galindo, David Antón-Martínez, María J Sanz, Jesús Agulla, José Castillo, Joaquín Jordán.   

Abstract

INTRODUCTION: After cerebral ischemia, necrotic cell death occurs specially for neurons, mainly due to the deprivation of oxygen and glucose. Cell necrosis triggers the activation of the immune system followed by an inflammatory response. This reaction is characterized by the activation of astrocytes and microglia together with the infiltration of peripheral immune cells. DEVELOPMENT: Both, microglia and inflammatory cells, including circulating peripheral inflammatory cells, get activated and release a plethora of inflammatory mediators, cytokines, chemokines, etc. Such released factors induce the overexpression of adhesion molecules, increasing the blood brain barrier permeability, thus favoring even more inflammatory cell infiltration. In the end, this contributes to increase brain damage. Inflammatory response is nevertheless necessary in order to eliminate cellular debris from both apoptotic and necrotic cells. It seems to be also implicated in the initiation of certain mechanisms responsible for brain repair and plasticity. As a result, the inflammatory response is a coordinated effort. Activation of inflammation triggers an immunosuppressant and anti-inflammatory response. A high rate of infections in patients suffering from stroke, together with increased serum levels of anti-inflammatory molecules in these patients, support this statement. The anti-inflammatory response could be interpreted as the organism attempting to control the heightened inflammatory response that occurs after cerebral ischemia. On the other hand, following an ischemic event, there are several new cerebral epitopes that get exposed to the immune system, which would never have been exposed under normal physiological conditions.
CONCLUSION: Therefore immunosuppression after an ischemic accident hinders the development of auto-immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568066

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  Immunomodulatory effect of Hawthorn extract in an experimental stroke model.

Authors:  Chinnasamy Elango; Sivasithambaram Niranjali Devaraj
Journal:  J Neuroinflammation       Date:  2010-12-30       Impact factor: 8.322

2.  Neuroprotective effect of a new synthetic aspirin-decursinol adduct in experimental animal models of ischemic stroke.

Authors:  Bing Chun Yan; Joon Ha Park; Bich Na Shin; Ji Hyeon Ahn; In Hye Kim; Jae-Chul Lee; Ki-Yeon Yoo; In Koo Hwang; Jung Hoon Choi; Jeong Ho Park; Yun Lyul Lee; Hong-Won Suh; Jong-Gab Jun; Young-Guen Kwon; Young-Myeong Kim; Seung-Hae Kwon; Song Her; Jin Su Kim; Byung-Hwa Hyun; Chul-Kyu Kim; Jun Hwi Cho; Choong Hyun Lee; Moo-Ho Won
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

3.  Heat-sensitive moxibustion attenuates the inflammation after focal cerebral ischemia/ reperfusion injury.

Authors:  Aijiao Xiao; Rixin Chen; Mingfei Kang; Shenghai Tan
Journal:  Neural Regen Res       Date:  2012-11-25       Impact factor: 5.135

4.  A possible role of microglia-derived nitric oxide by lipopolysaccharide in activation of astroglial pentose-phosphate pathway via the Keap1/Nrf2 system.

Authors:  Takuya Iizumi; Shinichi Takahashi; Kyoko Mashima; Kazushi Minami; Yoshikane Izawa; Takato Abe; Takako Hishiki; Makoto Suematsu; Mayumi Kajimura; Norihiro Suzuki
Journal:  J Neuroinflammation       Date:  2016-05-04       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.